Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive primary microcephaly in which the cause of the disease is a mutation in the CDK6 gene.
Features include always present findings: Sloping forehead, Mild intellectual disability, Primary microcephaly, and Simplified gyral pattern. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Mild intellectual disability, Seizure |
CDK6 encodes cyclin dependent kinase 6 (326 aa). Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. Phosphorylates pRB/RB1 and NPM1. Highest expression in Cells EBV-transformed lymphocytes (32.3 TPM) and Cells Cultured fibroblasts (19.7 TPM).
Microcephaly 12, primary, autosomal recessive is associated with mutations in the CDK6 gene on chromosome 7.
The CDK6 protein participates in CDK6 inhibitors bind CDK6, p16INK4A mutants do not bind CDK4,CDK6, and Association of INK4 family proteins with CDK4/6 pathways.
CDK6 is classified as a druggable target (Clinically Actionable, Drug Resistance, Druggable Genome, Enzyme, Kinase, Serine Threonine Kinase, and Tumor Suppressor categories) with score 3.1.
Genetic testing for CDK6 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features.
No clinical trials have been registered for microcephaly 12, primary, autosomal recessive.
6 publications have been identified in PubMed for microcephaly 12, primary, autosomal recessive. Research spans Basic Science / Preclinical (50%), Review / Meta-Analysis (17%), and Case Report / Case Series (17%).
Verdu Schlie A (2025). [PMID: 40210435](https://pubmed.ncbi.nlm.nih.gov/40210435/). *Genes Dev*. [Basic Science / Preclinical]
Khan MA (2025). [PMID: 40801391](https://pubmed.ncbi.nlm.nih.gov/40801391/). *J Genet*. [Basic Science / Preclinical]
Yoon JG (2025). [PMID: 40770811](https://pubmed.ncbi.nlm.nih.gov/40770811/). *Genome Med*. [Basic Science / Preclinical]
Paracha SA (2024). [PMID: 39281811](https://pubmed.ncbi.nlm.nih.gov/39281811/). *Front Med (Lausanne)*. [Epidemiology / Natural History]
Jiang C (2024). [PMID: 39698004](https://pubmed.ncbi.nlm.nih.gov/39698004/). *Clin Case Rep*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1 |
Primary microcephaly |